Parasternal Blockade and Serum Lactate in Cardiac Surgery
ConditionElective Cardiac Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstituto Mexicano del Seguro Social
About this trial
Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery in 2022 at Specialty Hospital CMNO. Patients with and without parasternal block were compared for changes in serum lactate levels during and after anesthesia within the first 24 hours.
Eligibility criteria
Qualifiers
Adult patients older than 18 years
Either sex
ASA II-III
Patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass.
Disqualifiers
Patients with pre-existing conditions that could independently affect serum lactate levels.
Trial design
Treatments tested in this trial
- Parasternal block
- Requirement of total dose regarding fentanyl
Treatment groups
86 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov